【结 构 式】 |
【分子编号】47293 【品名】4-(aminomethyl)benzonitrile 【CA登记号】 |
【 分 子 式 】C8H8N2 【 分 子 量 】132.165 【元素组成】C 72.7% H 6.1% N 21.2% |
合成路线1
该中间体在本合成路线中的序号:(XX)In a further procedure, bromide (XV) was reacted with hexamethylenetetramine in refluxing EtOH followed by acid hydrolysis to produce the benzyl amine (XX). Mercapto imidazole (XXII) was then obtained by condensation of amine (XX) with dihydroxyacetone (XXI) and KSCN. Subsequent oxidative desulfuration gave the hydroxymethyl imidazole (XVIII). This was converted to the corresponding chloride (XXIII) by treatment with either SOCl2 in DMF or the Vilsmeier reagent. Finally, chloride (XXIII) was condensed with piperazinone (VIII) in the presence of diisopropylethylamine.
【1】 Cowen, J.A.; Askin, D.; McWilliams, J.C.; Maligres, P.E.; McCauley, J.A. (Merck & Co., Inc.); Process for making farnesyl-protein transferase inhibitors. WO 0001691 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VIII) | 47289 | 1-(3-chlorophenyl)-2-piperazinone | C10H11ClN2O | 详情 | 详情 | |
(XV) | 14200 | 4-(Bromomethyl)benzonitrile; alpha-Bromo-p-tolunitrile | 17201-43-3 | C8H6BrN | 详情 | 详情 |
(XVIII) | 38389 | 4-[[5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]benzonitrile | C12H11N3O | 详情 | 详情 | |
(XX) | 47293 | 4-(aminomethyl)benzonitrile | C8H8N2 | 详情 | 详情 | |
(XXI) | 14575 | Dihydroxyacetone; 1,3-dihydroxyacetone | 96-26-4 | C3H6O3 | 详情 | 详情 |
(XXII) | 47294 | 4-[[5-(hydroxymethyl)-2-sulfanyl-1H-imidazol-1-yl]methyl]benzonitrile | C12H11N3OS | 详情 | 详情 | |
(XXIII) | 47295 | 4-[[5-(chloromethyl)-1H-imidazol-1-yl]methyl]benzonitrile | C12H10ClN3 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)The N-protected dipeptide (I) is coupled to 4-(aminomethyl)benzonitrile (II) by means of EDC to afford amide (III). Acidic cleavage of the N-Boc group of (III) yields the deprotected amine (IV), which is then condensed with sulfamoyl chloride, producing sulfamide (V). From this, the target amidine can be obtained in two ways. Addition of hydrogen sulfide to the cyano group of (V), followed by S-alkylation with iodomethane, gives rise to the thioimidate (VI), which is then displaced with ammonium acetate to provide the desired amidine. Alternatively, addition of hydroxylamine to nitrile (V) leads to the amidoxime (VII) which, upon catalytic hydrogenation, is converted into the title amidine.
【1】 Kwon, O.H.; Lee, S.H.; Park, H.D.; Jung, W.-H.; Lee, K.; Park, C.W.; Noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1. Bioorg Med Chem Lett 2002, 12, 7, 1017. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 58971 | (2S)-1-{(2R)-2-[(tert-butoxycarbonyl)amino]-3,3-diphenylpropanoyl}-2-pyrrolidinecarboxylic acid | C25H30N2O5 | 详情 | 详情 | |
(II) | 47293 | 4-(aminomethyl)benzonitrile | C8H8N2 | 详情 | 详情 | |
(III) | 58972 | C33H36N4O4 | 详情 | 详情 | ||
(IV) | 58973 | (2S)-1-[(2R)-2-amino-3,3-diphenylpropanoyl]-N-(4-cyanobenzyl)-2-pyrrolidinecarboxamide | C28H28N4O2 | 详情 | 详情 | |
(V) | 58974 | (2S)-1-{(2R)-2-[(aminosulfonyl)amino]-3,3-diphenylpropanoyl}-N-(4-cyanobenzyl)-2-pyrrolidinecarboxamide | C28H29N5O4S | 详情 | 详情 | |
(VI) | 58975 | methyl 4-({[((2S)-1-{(2R)-2-[(aminosulfonyl)amino]-3,3-diphenylpropanoyl}pyrrolidinyl)carbonyl]amino}methyl)benzenecarbimidothioate | C29H33N5O4S2 | 详情 | 详情 | |
(VII) | 58976 | (2S)-N-{4-[amino(hydroxyimino)methyl]benzyl}-1-{(2R)-2-[(aminosulfonyl)amino]-3,3-diphenylpropanoyl}-2-pyrrolidinecarboxamide | C28H32N6O5S | 详情 | 详情 |